Technology & innovation

Neurons inside human brain

Synapse-restoring pill set for human trials as novel schizophrenia treatment

Spinogenix is the American company behind the once-a-day pill that restored lost nerve cell connections in people with amyotrophic lateral sclerosis (ALS). Having been granted approval from the Australia Human Research Ethics Committee (HREC), it is now actively enrolling participants for its Phase 2 clinical trial to evaluate the safety, effectiveness, tolerability, and pharmacodynamics of once-a-day SPG302 as a treatment for schizophrenia.

Green ammonia plant

World’s first green ammonia plant is now open for business in Denmark

The new plant – located in Ramme, Denmark – is said to be capable of producing 5,000 tons of green ammonia per year, entirely from solar and wind energy. Topsoe reports that this effort will prevent 8,200 tons of carbon dioxide emissions annually. Gray ammonia production – which uses fossil fuels – is currently the norm around the globe, and accounts for about 1.2% of all carbon dioxide emissions.

Model lungs

World-first lung cancer vaccine trials launched across seven countries

Lung cancer is the world’s leading cause of cancer death, accounting for about 1.8 million deaths every year. Now experts are testing a new jab that instructs the body to hunt down and kill cancer cells – then prevents them from ever coming back. Known as BNT116 and made by BioNTech, the vaccine is designed to treat non-small cell lung cancer, the most common form of the disease. The phase 1 clinical trial, the first human study of BNT116, has launched across 34 research sites in seven countries: the U.K., U.S., Germany, Hungary, Poland, Spain, and Turkey.

Honeycomb

Manuka honey reduces breast cancer cell growth by 84% in preliminary studies

Manuka honey is produced from the nectar collected by honey bees when they pollinate the mānuka, a species of tea tree indigenous to New Zealand and southeast Australia. Now, preliminary studies by researchers at UCLA have found that this nutraceutical might aid in breast cancer prevention and treatment. The honey-treated mice showed significantly suppressed tumor growth compared to controls. Overall, it inhibited the growth and progression of an established human breast cancer tumor by 84% without affecting healthy cells.

MIT naloxone sensor implant

MIT scientists reverse opioid overdoses with ‘Narcan sensor’ implanted under skin

In 2023, more than 100,000 Americans died from opioid overdoses. The most effective way to save someone who has overdosed is to administer a drug called naloxone, but help can’t always reach the person in time. Researchers at MIT and Brigham and Women’s Hospital have developed a new device to address this problem. The device, about the size of a stick of gum, can be implanted under the skin. When it determines that an overdose has occurred, it rapidly pumps out a dose of naloxone.

Seastar

Lab-grown starfish released into wild for the first time ever, saving species from extinction

Due to sea star wasting disease, lower oxygen levels in seawater, and rising temperatures, starfish populations are at risk around the globe. Across the last decade, the sunflower star population plummeted by over 90%. Fortunately, in 2019, marine biologist Jason Hodin stepped up to save the sea stars from extinction. At the University of Washington’s Friday Harbor Labs, Hodin has carefully grown and raised several generations of sunflower starfish in a controlled environment, breeding them from a select sample of starfish he rescued from the harbor five years prior.

Mt. Everest

Chinese drones to transport trash from Nepal’s Mount Everest

Nepal is set to deploy Chinese-made drones to transport garbage from the slopes of Everest, marking the first time unmanned aerial vehicles (UAVs) will be used commercially in the country’s high-altitude zones. This initiative announced by China’s leading drone manufacturer, Da Jiang Innovations aims to reduce the risks faced by Sherpas and improve waste management on the world’s tallest peak.

Vials of blood

U.S. Food and Drug Administration approves blood test to screen for colon cancer

The test, known as Shield, isn’t meant to replace colonoscopies, but is generating enthusiasm among doctors who say it has the potential to boost the dismal rate of screenings for the second-highest cause of cancer death in the United States. Shield has previously been available to doctors as a screening tool, at an out-of-pocket cost of $895. With the FDA approval, Medicare and private insurance companies are much more likely to cover the cost of the blood test, making it more widely accessible for patients.

Ocean Energy grid-scale wave energy generator Hawaii

Revolutionary grid-scale wave energy generator deployed in Hawaii

Ocean Energy has deployed its 826-tonne wave energy converter buoy OE-35 at the US Navy’s Wave Energy Test Site off the coast of the island of Oahu ahead of it being hooked up to Hawaii’s electricity grid. With a potential output of 1.25 MW, OE-35 harnesses energy from the waves using a remarkable double-flow air system.

Fervo Energy geothermal plant

World’s biggest geothermal power purchase agreement completed in western U.S.

It’s only been one year since Fervo Energy unveiled a novel concept in geothermal energy harvesting at its Project Red pilot plant in Nevada. Now the company has signed a 15-year agreement with Southern California Edison to provide 320 MW of power to the utility, which will power about 350,000 homes. The power will be provided by Fervo’s Cape Station project that is currently being built in southwest Utah, with the first 70 MW coming online in 2026 and the balance clicking on in 2028.

Scroll to Top